155 related articles for article (PubMed ID: 37981080)
1. Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer.
Li D; Weng S; Zeng K; Xu H; Wang W; Shi J; Chen J; Chen C
Gene; 2024 Feb; 895():148007. PubMed ID: 37981080
[TBL] [Abstract][Full Text] [Related]
2. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
3. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer.
Xie W; Chu M; Song G; Zuo Z; Han Z; Chen C; Li Y; Wang ZW
Semin Cancer Biol; 2022 Aug; 83():303-318. PubMed ID: 33207266
[TBL] [Abstract][Full Text] [Related]
4. Identification of key lncRNAs in the tumorigenesis of intraductal pancreatic mucinous neoplasm by coexpression network analysis.
Ding J; Li Y; Zhang Y; Fan B; Li Q; Zhang J; Zhang J
Cancer Med; 2020 Jun; 9(11):3840-3851. PubMed ID: 32239802
[TBL] [Abstract][Full Text] [Related]
5. Roles of lncRNAs in pancreatic ductal adenocarcinoma: Diagnosis, treatment, and the development of drug resistance.
Jiang XY; Zhu QC; Zhang XJ; Duan T; Feng J; Sui XB; Sun XN; Mou YP
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):128-139. PubMed ID: 36543619
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer.
Xiong G; Liu C; Yang G; Feng M; Xu J; Zhao F; You L; Zhou L; Zheng L; Hu Y; Wang X; Zhang T; Zhao Y
J Hematol Oncol; 2019 Sep; 12(1):97. PubMed ID: 31514732
[TBL] [Abstract][Full Text] [Related]
7. The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a.
Chen B; Li Q; Zhou Y; Wang X; Zhang Q; Wang Y; Zhuang H; Jiang X; Xiong W
Cell Cycle; 2018; 17(16):1949-1966. PubMed ID: 30300116
[TBL] [Abstract][Full Text] [Related]
8. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway.
Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G
Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522
[TBL] [Abstract][Full Text] [Related]
9. Identification of lncRNAs and Their Functional Network Associated with Chemoresistance in SW1990/GZ Pancreatic Cancer Cells by RNA Sequencing.
Li D; Qian X; Xu P; Wang X; Li Z; Qian J; Yao J
DNA Cell Biol; 2018 Oct; 37(10):839-849. PubMed ID: 30113217
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
Yan J; Jia Y; Chen H; Chen W; Zhou X
J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
[TBL] [Abstract][Full Text] [Related]
12. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes.
Zhou C; Yi C; Yi Y; Qin W; Yan Y; Dong X; Zhang X; Huang Y; Zhang R; Wei J; Ali DW; Michalak M; Chen XZ; Tang J
Mol Cancer; 2020 Jul; 19(1):118. PubMed ID: 32727463
[TBL] [Abstract][Full Text] [Related]
13. Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression.
Yoshida K; Toden S; Ravindranathan P; Han H; Goel A
Carcinogenesis; 2017 Oct; 38(10):1036-1046. PubMed ID: 29048549
[TBL] [Abstract][Full Text] [Related]
14. Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review.
Al-Noshokaty TM; Mansour A; Abdelhamid R; Abdellatif N; Alaaeldien A; Reda T; Abdelmaksoud NM; Doghish AS; Abulsoud AI; Elshaer SS
Pathol Res Pract; 2023 May; 245():154438. PubMed ID: 37043965
[TBL] [Abstract][Full Text] [Related]
15. The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential.
Pandya G; Kirtonia A; Sethi G; Pandey AK; Garg M
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188423. PubMed ID: 32871244
[TBL] [Abstract][Full Text] [Related]
16. The involvement of lncRNAs in the development and progression of pancreatic cancer.
Duguang L; Jin H; Xiaowei Q; Peng X; Xiaodong W; Zhennan L; Jianjun Q; Jie Y
Cancer Biol Ther; 2017 Dec; 18(12):927-936. PubMed ID: 29053398
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA MACC1-AS1 promoted pancreatic carcinoma progression through activation of PAX8/NOTCH1 signaling pathway.
Qi C; Xiaofeng C; Dongen L; Liang Y; Liping X; Yue H; Jianshuai J
J Exp Clin Cancer Res; 2019 Aug; 38(1):344. PubMed ID: 31391063
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNAs (lncRNAs) in pancreatic cancer progression.
Ashrafizadeh M; Rabiee N; Kumar AP; Sethi G; Zarrabi A; Wang Y
Drug Discov Today; 2022 Aug; 27(8):2181-2198. PubMed ID: 35589014
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
